Interim

Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study – Eliem Therapeutics (NASDAQ:ELYM)

General

Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study – Eliem Therapeutics (NASDAQ:ELYM)

By Carmen N. Inman 2 years ago

&#13 Eliem Therapeutics Inc ELYM announced interim results from its ongoing Stage 1 demo of ETX-155 for important